[
    {
        "file_name": "coherusbiosciencesinc_20200227_10-k_ex-10.29_12021376_ex-10.29_development agreement.pdf",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the Parties.",
                "changed_text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the Companies.",
                "explanation": "The terms “Parties” and “Companies” are used interchangeably, leading to potential confusion about the specific entities involved. While seemingly synonymous, using different terms without clear definitions can create ambiguity in interpreting the contract's provisions related to responsibilities and rights.",
                "location": "Introductory Paragraph"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "LICENSE AND DEVELOPMENT AGREEMENT\nThis LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019\n(the Effective Date) by and between Bioeq IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,\nhaving its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).\nBioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the Parties.",
                "changed_text": "LICENSE AND DEVELOPMENT AGREEMENT\nThis LICENSE AND DEVELOPMENT AGREEMENT (this Contract) is entered into effective as of Nov. 02, 2019\n(the Effective Date) by and between Bioeq IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,\nhaving its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Recipient).\nBioeq and Recipient shall also each individually be referred to herein as a Party, and shall be referred to jointly as the Companies.",
                "explanation": "Multiple key terms are changed in this section. 1. 'Agreement' is changed to 'Contract'. 2. 'Licensee' is changed to 'Recipient'. 3. 'Party' is changed to 'Companies'. Due to these changes, it can lead to confusion and may result in disputes over which obligations are to be enforced.",
                "location": "LICENSE AND DEVELOPMENT AGREEMENT"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "1.10 Commercialization means the conduct of all activities undertaken before and after Regulatory Approval relating to the promotion, marketing, sale and distribution (including importing, exporting, transporting, customs clearance, warehousing, invoicing, handling and delivering products to customers) of pharmaceutical products, including: (a) sales force efforts, detailing, advertising, medical education, planning, marketing, sales force training and sales and distribution; and (b) scientific and medical affairs. For clarity, Commercialization does not include any Development activities, whether conducted before or after Regulatory Approval. “Commercialize” and “Commercializing” have correlative meanings.",
                "changed_text": "1.10 Marketing refers to the conduct of all activities undertaken before and after Regulatory Approval relating to the promotion, marketing, sale and distribution (including importing, exporting, transporting, customs clearance, warehousing, invoicing, handling and delivering products to consumers) of pharmaceutical products, including: (a) sales force efforts, detailing, advertising, medical education, planning, marketing, sales force training and sales and distribution; and (b) scientific and medical affairs. For clarity, Marketing does not include any Development activities, whether conducted before or after Regulatory Approval. “Market” and “Marketing” have correlative meanings.",
                "explanation": "The term “Commercialization” is replaced with “Marketing” without any note on if it is synonymous to what was previously defined. This change will create contradiction when the 'Commercialization Plan' is mentioned in section 6.3, it would be unclear if that is relevant anymore.",
                "location": "Section 1.10"
            }
        ]
    }
]